Parkinson's Disease

Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which dep...

Atrial Fibrillation and WolffParkinsonWhite Syndrome WPW

Metabotropic Glutamate Receptor 4 (mGluR4)

Metabotropic glutamate receptor 4 is a protein that in humans is encoded by the GRM4 gene. Together with GRM6, GRM7 and GRM8 it belongs to group III of the metabotropic glutamate receptor famil...

Selective monoamine oxidase type B MAOB inhibitors

The clinical benefit of monoamine oxidase type B (MAO-B) inhibitors is thought to arise from an ability of these medications to enhance the level of dopamine by decreasing the catabolism. Additional...

Neurotrophic Growth Factors NGF BDNF CNTF

Early clinical trials with classical neurotrophic growth factor proteins such as NGF, BDNF, CNTF have failed for various reasons including safety, efficacy and convenience of administration as well as...

Early Diagnosis Of Parkinson's May Be Possible With Discovery Of New Antibody

Around 15,000 to 16,000 Austrian's suffer from Parkinson's disease, a degenerative condition of the brain, which becomes more prevalent with age. The frequency of Parkinson's disease will become more...

All-Purpose Workbench

Lista International Corp. has introduced is All-Purpose Workbench, a versatile, general-purpose workbench. The workbench features a durable design and is capable of supporting 1,000 lbs, evenly distr...

Parkinson’s UK welcomes introduction of Best Practice Tariff for Parkinson’s

 Parkinson’s UK today welcomes the introduction of the Department of Health’s new Best Practice Tariff (BPT) for Parkinson’s. It is hoped that the tariff – which will encourage first-clas...

Depression a Key Factor in Health of Parkinson's Patients: Study

WEDNESDAY, Nov. 28 (HealthDay News) -- Depression is the most important determinant of the health status of people with Parkinson's disease, according to early findings from a large study of Parkins...

'Clean-Up' Snafu That Kills Brain Cells In Parkinson's Disease Identified

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the most common genetic mutations in familial Parkinson's disease damage brain cells. The study, which publ...

Anonymous survey launched for Parkinson’s patients to collect data for research to help determine the cause of Parkinson's disease.

Yelm, Wa (PRWEB) February 20, 2013 An anonymous survey has been launched by the Parkinson’s Database Coalition for those afflicted with Parkinson’s disease. The survey is for Parkins...

Potential Link Revealed Between Parkinson's And Visual Problems

The most common genetic cause of Parkinson's is not only responsible for the condition's distinctive movement problems but may also affect vision, according to new research by scientists at the Univer...

People With Parkinson's Subject To 'Intolerable' Discrimination And Prejudice

Four in ten people with Parkinson's experience discrimination because of their condition People with Parkinson's are being subjected to 'intolerable' levels of prejudice and discrimination by institut...

Parkinson disease: Improving quality of care in Parkinson disease.

Pragmatic Communication is Impaired in Parkinson Disease.

ABSTRACT The purpose of this study was to determine whether severity of disease, cognitive function, age, gender, or amount of social interaction were associated with pragmatic dysfunction in Parkinso...

Parkinson disease: Twin study identifies an association between exposure to a solvent and risk of Parkinson disease.

Parkinson disease: Cognitive behavioural therapy improves impulse control in patients with Parkinson disease.

Parkinson disease: Constant-current deep brain stimulation improves symptoms in Parkinson disease.